This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland
Book Now
Menu
Book

Ross Kelly, PhD
Associate Principal Scientist at AstraZeneca
Speaker

Agenda Sessions

  • SubQ-Sim: A Physiologically-Based Biopharmaceutical Model (PBBM) for Advancing Oligonucleotide Subcutaneous Drug Delivery

    , 09:55
    View Session

At this event

Prev
Next
Martin Kenworthy, PhD
Principal Scientist, Chemical Development
AstraZeneca

See Ross at TIDES Europe: Oligonucleotide and Peptide Therapeutics

Book Now